Introduction
Up to half of cancer patients experience acute kidney injury (AKI) and the majority of them require renal replacement therapy (RRT) while in the intensive care unit (ICU) [1] [2] [3] [4] [5] [6] [7] . AKI in these patients occurs either as a consequence of the cancer itself (urinary tract obstruction, acute tumour lysis syndrome), anticancer treatments (drug-induced nephropathy, major surgical procedures) or diverse-associated severe clinical conditions (sepsis, hypovolaemia) [1, 8] .
Although survival seems to be improving over the last decade, the development of AKI in critically ill cancer patients remains associated with high mortality rates [2, 3, 7, [9] [10] [11] [12] [13] . In addition, the diagnosis of a malignancy per se seems to be no longer independently associated with a higher risk of death [2, 3] . However, the few studies on this specific subgroup of ICU cancer patients were performed in specialized ICUs, thereby imposing restrictions to the generalization of results to general ICUs [2, 3, 7, [9] [10] [11] 14] . Therefore, we performed the present multicentre study with three major aims: (i) to evaluate and compare the characteristics and outcomes of cancer and non-cancer ICU patients with AKI requiring RRT, (ii) to determine the impact of cancer diagnosis on hospital mortality in critically ill AKI patients and (iii) to compare outcome predictors between the two groups of patients.
Materials and methods

Design and setting
This was a prospective observational study conducted from December 2004 to July 2008 at 14 ICUs of three tertiary care hospitals in Rio de Janeiro, Brazil. The ICUs included four medical-surgical ICUs, three coronary/cardiac surgery units, two neurological, one respiratory care, two medical and two surgical ICUs. The ethics committees at each site approved the study and the need for informed consent was waived. The study was absolutely observational and all decisions related to patients' care [including end-of-life (EOL) decisions] were at discretion of the medical team responsible for the patients. EOL decisions (to withhold or withdraw life-sustaining therapies) were generally taken in patients who did not recover from the acute illness despite full ICU care.
Selection of participants, data collection and definitions
Patients were retrieved from a prospective cohort of patients who received RRT during the ICU stay at the participating hospitals during the study period. Both patients with AKI and acute on chronic kidney injury were evaluated. Patients with chronic kidney injury had a previous glomerular filtration rate <60 mL/min/per 1.73 m 2 for at least 3 months [15] . Patients with non-renal indications for RRT, end-stage renal disease requiring chronic dialysis and those with ICU stay <24 h and readmissions were not considered. Patients with cancer must have had a pathologically proven diagnosis of malignancy. For the purpose of the present study, cancer patients were classified into three major groups: haematological malignancies, solid tumour with locoregional involvement and solid tumour with distant metastasis.
Demographic, clinical and laboratory data were prospectively collected including hospital location before ICU admission, main diagnosis for ICU admission, comorbidities, previous chronic health status (Knaus scale: A: no limitation of activity, B: moderate limitation, C: severe limitation and D: bedridden or institutionalized) [16] , pre-morbid renal function and the Simplified Acute Physiology Score (SAPS) II at ICU admission [17] , and contributing factors for AKI were also recorded. The measurement of comorbidities was performed using the Charlson comorbidity index [18] . The Sequential Organ Failure Assessment (SOFA) score [19] , the need for mechanical ventilation (MV) and vasopressors for >24 h on the first day of RRT were recorded and considered in the analysis. Individual organ failures were defined as a SOFA score ≥2 points in each domain [20] . Multiple organ failure was defined as the presence of ≥2 associated organ failures. Patients were classified based on the reason for ICU admission in medical, scheduled surgical and emergency surgical. Infection was defined as the presence of a pathogenic microorganism in a sterile milieu (such as blood or cerebrospinal fluid) and/or clinically suspected infection that justified the administration of antibiotics [20] . Sepsis was diagnosed according to the current definitions [21] . Vital status at hospital discharge was the outcome of interest.
AKI was classified using the RIFLE [R (risk); I (injury); F (failure); L (loss) E (end-stage renal disease)] criteria [22] at the time of initiation of RRT [15] . Urine output <400 mL/day was considered as oliguria. Decisions to start, change the method and cease RRT were taken together by the nephrologist and the intensivist responsible for the patient on an individual basis. The decision to start RRT was based on the presence of one or more of the following characteristics: metabolic acidosis, urea above 100 mg/ dL, hyperkalaemia above 6.0 mEq/L, evidence of Volume overload, severe hyperphosphataemia or dysnatraemia, oligoanuria and uraemic signs or symptoms [15] . Prescribed RRT modes were daily conventional dialysis, daily extended dialysis and continuous RRT (CRRT) taking into consideration the patient's haemodynamic status, being CRRT employed in patients receiving vasoactive drugs and in those with potential for haemodynamic instability [15] . FAD 100 (Braun, Rio de Janeiro, Brazil) and Prisma or AK series (Gambro ® ) machines, and polisulfone (F series, Fresenius ® ) and AN69S (Gambro ® ) membranes were used in the RRT procedures. Customized dialysis and replacement solutions were prescribed on a daily basis aiming to optimize patient's metabolic control and were produced at the hospital pharmacy as appropriate.
Data processing and statistical analysis
Data were entered in a computer database by a single data manager. Data consistency was assessed by a single author (M.S.) through a rechecking procedure of a 10% random sample of patients. All entered data were also checked for outlying and implausible values. Continuous variables were presented as mean ± standard deviation or median (25-75% interquartile range). Univariate and multivariate logistic regression analyses were used to identify factors associated with hospital mortality [23] . Linearity between each continuous variable and the dependent variable was demonstrated using locally weighted scatterplot smoothing [23] . In case of nonlinearity, the variable was stratified according to the inflection points and clinical significance. For categorical variables with multiple levels, the reference level was attributed to the one with the lowest probability of the dependent variable. Variables yielding P-values <0.2 by univariate analysis and those considered clinically relevant were entered in the multivariate analysis to estimate the independent association of each covariate with the dependent variable. SAPS II was not entered in the multivariate analyses because it encompasses other covariates such as age, variables used to define organ failures, severe comorbidities and underlying malignancies [17] . Results were summarized as odds ratios (OR) and respective 95% confidence intervals (CI). Possible interactions were tested. The area under the receiver operating characteristic curve (AROC) was used to assess the models' discrimination; an AROC of 1.0 denotes perfect, while a value close to 0.50 indicates no apparent accuracy [24] . The HosmerLemeshow goodness-of-fit test was used to evaluate agreement between the observed and expected results across all strata of probabilities of the outcome of interest (calibration) [23] . With this test, P-values >0.05 indicate a good fit for the model. Two-tailed P-values <0.05 were considered statistically significant. Statistical analyses were carried out with SPSS for Windows, version 13.0 (SPSS Inc., Chicago, IL).
Results
Characterization of the study population
A total of 773 patients with a mean age of 70.5 ± 16.0 years were included over the study period, and out of them, 118 (15%) had a proven diagnosis of a malignancy. From these patients, 86 (73%) had solid tumours and 32 (27%) had haematological malignancies. The most frequent type of malignancies were lower gastrointestinal (n = 25, 21%), urogenital (n = 18, 15%), liver and billiary tract (n = 15, 13%), upper gastrointestinal (n = 11, 9%), leukaemias (n = 10, 8%), multiple myeloma (n = 7, 6%), nonHodgkin's lymphoma (n = 6, 6%), lung (n = 6, 5%) and others (n = 20, 17%). The main patient characteristics are depicted in Table 1 .
Patients were usually admitted to the ICU because of a medical complication. Six hundred and fourteen (79%) patients had comorbidities other than cancer and the most frequent were systemic arterial hypertension (71%), diabetes (32%), coronary artery disease (28%), chronic heart failure (22%), chronic pulmonary disease (14%) and cirrhosis (6%). Excluding cancer-related points, cancer and non-cancer patients were similar in terms of severity of illness evaluated by the SAPS II score. However, the severity of organ dysfunctions was higher in patients with cancer.
Clinical and laboratory data related to kidney function are shown in Table 2 . RRT was implemented at 3 (1-10) days of ICU stay and most of the patients were classified as failure (55%) according to RIFLE immediately before the start of RRT. CRRT was the preferential initial modality of RRT (79%) and was more frequently used in cancer patients (89 vs 77%, P = 0.017). Azotaemia, evidence of Volume overload and metabolic acidosis were the main indications to start RRT in both groups. However, metabolic acidosis was more frequent in patients with cancer (65 vs 48%, P = 0.016). The main contributing factors for AKI were sepsis (72%), ischaemia/shock (66%) and contrast/nephrotoxins (24%). AKI was usually multifactorial (>1 contributing factor for AKI) (73%), particularly in patients with cancer (87 vs 71%, P < 0.001). All urinary tract obstructions observed in cancer patients (n = 7) were related to the malignancy. No patient experienced acute tumour lysis syndrome.
Outcome analysis
The main patients' outcome data were generally similar in cancer and non-cancer patients, except for a higher hospital mortality observed in patients with cancer (Table 1) . Of note, no differences among the frequencies of EOL de- Outcomes of cancer and non-cancer patients with AKIcisions were observed. Twenty-six (22%) cancer patients and 209 (32%) non-cancer patients were discharged alive from the hospital. Out of them, 4 (15%) and 66 (32%) were still on RRT, and 22 (85%) and 143 (68%) were no longer requiring the continuing of RRT at hospital discharge (P = 0.140), respectively. The results of univariate analyses of factors associated with increased hospital mortality are depicted in Table 3 . Studying all 773 patients, non-survivors were older than survivors (73.6 ± 13.8 vs 63.4 ± 18.2 years, P < 0.001). As expected, non-survivors had higher SAPS II and SOFA (except renal domain) score points and required MV and vasopressors more frequently.
Older age, gender, poor chronic health status, hospital days prior to ICU admission, presence of comorbidities, the number of associated organ dysfunctions, the diagnosis of cancer, need for MV, ICU days until the start of RRT, previous chronic kidney injury, oliguria, RIFLE classification, sepsis, multifactorial AKI and lactate levels were entered in a multivariate logistic regression analysis having the hospital mortality as the dependent variable. The final model is presented in Table 4 and had both good discrimination and calibration. Adjusting for other covariates, the diagnosis of cancer was not independently associated with increased hospital mortality [OR = 1.54 (95% CI, 0.88-2.62), P = 0.115].
Finally, differences between outcome predictors in noncancer and cancer patients were explored and two models were fitted (Table 5) . Univariate analyses are reported in Tables 1 and 2 of the online supplementary material. Hospital mortality in non-cancer patients was dependent on older age, poor chronic health status, presence of comorbidities other than cancer, number of failing organs, need for MV and time to start of RRT in the ICU. In patients with cancer, adjusting for the type of ICU admission and the time until the start of RRT, mortality was mostly dependent on the number of associated organ dysfunctions (Table 5) .
Discussion
In this large prospective multicentre study, patients with cancer accounted for 15% of all patients with AKI requiring RRT in the participating ICUs. The few studies comparing characteristics and outcomes between critically ill Comparisons between cancer and non-cancer patients.
cancer and non-cancer patients presenting with this severe complication were conducted in specialized ICUs in referral cancer centres [2, 3] . In those studies, most of the patients had haematological malignancies [2, 3] . The present study was carried out in general ICUs and, as expected, patients more frequently had solid tumours. Such findings are in accordance with those reported in two recent multicentre studies on patients with cancer requiring ICU admission [20, 25] . AKI in patients with cancer was more frequently multifactorial and developed usually in the context of multiple organ failure than non-cancer patients. Moreover, CRRT was more frequently used in patients with cancer as these patients presented with higher severity of organ dysfunctions and required more often using vasopressors than non-cancer patients. Despite relatively higher hospital mortality, ICU mortality rates and duration of hospitalization were comparable between cancer and non-cancer patients. However, mortality rates reported for both non-cancer and cancer patients are in agreement to current literature [2, 3, 7, 11, 15, [25] [26] [27] [28] [29] . More importantly, adjusting for other prognostic factors, the diagnosis of cancer per se was not independently associated with a worse outcome. The higher mortality rate in patients with cancer can be attributed to a more pronounced severity of associated organ dysfunctions upon the start of RRT as expressed by higher SOFA scores. Of note, > 85% of surviving cancer patients were not dependent on RRT at hospital discharge. Corroborating the findings of the present study, in the study by Soares et al., renal function recovered in 82% of patients at 6 months of follow-up [7] .
We performed multivariate analyses to identify independent predictors of hospital mortality and three models were fitted. Adjusting for other covariates, including the presence of a malignancy, outcomes in RRT patients were mostly dependent on well-known predictors of mortality Outcomes of cancer and non-cancer patients with AKIsuch as older age, poor chronic health status, presence of comorbidities, number of failing organs, time to start of RRT in the ICU and oliguria [15, 25, 27, 28] . Our results also reinforce that the main prognostic factor in critically ill patients with cancer is the severity of organ dysfunctions [3, 7, 10, 13, 25] .
Nevertheless, many limitations must be taken into consideration in our study. First, data were retrieved from a large prospective database of three tertiary care hospitals. Although the type of cancer was known in all patients and the performance status could be deduced from the chronic health status, additional data to better characterize the underlying malignancy (e.g. presence of neutropaenia, disease stage and status, cancer-related complications) and anticancer treatments were unavailable. Additionally, we were not able to analyse subgroups of patients with cancer, and hence, the present study is underpowered to evaluate patients with haematological malignancies. However, we believe that our results may be more representative of the general practice in non-specialized hospitals and therefore more suitable to generalization. In large multicentre studies in general ICUs, patients with cancer accounted for 10 to 21% of all admissions, and solid tumours were much more frequent than haematological malignancies [20, 25, 30] . Second, we cannot rule out possible selection biases concerning regional specificities related to standards of care, including criteria used to start dialysis, implement EOL decisions and ICU admission/discharge policies. Third, bone marrow transplant (BMT) patients were not evaluated as this treatment is not regularly performed in non-specialized centres. In addition, we consider that BMT (in particular, allogeneic BMT) patients should be studied separately as they have peculiarities that differentiate them in terms of outcomes with mortality rates that remain disproportionably high when RRT is required because of AKI [2, 31] . Finally, endpoints in outcome studies should not be restricted to survival. Although we have evaluated the recovering of renal function at hospital discharge, it is necessary to evaluate and compare survival rates, renal function and aspects related to quality of life in medium-and long-term follow-up [32] . Particularly in patients with cancer, it is also needed to study the impact of AKI on the continuation of anticancer treatments [32] .
Conclusion
In summary, one in six patients requiring RRT in general ICUs has cancer. Despite a relatively higher mortality, the presence of cancer was not independently associated with increased mortality in the present cohort. However, additional studies are needed to compare the outcomes of cancer patients admitted to specialized and general ICUs.
